Most people see reflux resolve within 2 to 4 weeks of stopping the medication
The FDA-approved pre-filled pen devices are specifically engineered to deliver accurate milligram doses through built-in dose selectors or fixed single-dose mechanisms, eliminating the need for unit-based calculations and significantly reducing the risk of potentially dangerous dosing errors
Practical Considerations Several practical factors affect GLP-1 medication use
Gastrointestinal (GI) side effects, such as nausea, diarrhea, and vomiting, are most commonly associated with this medication
Furthermore, in New Zealand obese mice, the GLP-1-estradiol conjugate protects against carbohydrate-induced hyperglycemia (250)
These medications are FDA-approved primarily for the treatment of type 2 diabetes mellitus, with some formulations also approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity